Illumina's divestiture of GRAIL boosts financials, while strong gross margins and DNA sequencing growth drive potential. See ...

All human whole-genome sequencing initiatives should be conducted under a formal research protocol, and ought to include the development of a data return and counselling policy that can be ...

Overview of Genomics in Cancer Care MarketThe global Genomics in Cancer Care Market is valued at USD 24.5 Billion in 2024 and ...

Solexa, Inc., later acquired by Illumina, released its platform, which combines sequencing-by-synthesis chemistry and cluster technology, in June 2006 (see 'Creating the Genome Analyzer').

The rapid identification of respiratory virus outbreaks is needed to enable rational and effective public health interventions. We developed new quantitative approaches for simultaneous ...

The Global Multi-omics Market comprising primarily Genomics, Transcriptomics, Proteomics, & Metabonomics is set to witness a ...

In this interview, the team at n6 discusses their groundbreaking iconPCR thermocycler and its impact on laboratory automation ...